{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:47:32Z","timestamp":1780361252549,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00261-017-1454-3","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T08:41:24Z","timestamp":1519029684000},"page":"2369-2374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT"],"prefix":"10.1007","volume":"43","author":[{"given":"Tima","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldar","family":"Priel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginette","family":"Schiby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bar","family":"Chikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Nissan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohad","family":"Benjamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnatan","family":"Nissan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinor","family":"Goshen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ben-Haim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ophira","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Avigdor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"issue":"10","key":"1454_CR1","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","volume":"104","author":"KA Blum","year":"2004","unstructured":"Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104(10):3009\u20133020. \n                    https:\/\/doi.org\/10.1182\/blood-2004-02-0405","journal-title":"Blood"},{"issue":"9822","key":"1454_CR2","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","volume":"379","author":"EM Molyneux","year":"2012","unstructured":"Molyneux EM, Rochford R, Griffin B, et al. (2012) Burkitt\u2019s lymphoma. Lancet 379(9822):1234\u20131244. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(11)61177-X","journal-title":"Lancet"},{"key":"1454_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fmed.2014.00054","volume":"1","author":"C Bailly","year":"2014","unstructured":"Bailly C, Eugene T, Couec ML, et al. (2014) Prognostic value and clinical impact of (18)FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy. Front Med (Lausanne) 1:54. \n                    https:\/\/doi.org\/10.3389\/fmed.2014.00054","journal-title":"Front Med (Lausanne)"},{"key":"1454_CR4","first-page":"181","volume-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues World Health Organization classification of tumors","author":"J Diebold","year":"2001","unstructured":"Diebold J, Jaffe ES, Raphael M, Warnke RA (2001) Burkitt lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) Pathology and genetics of tumours of haematopoietic and lymphoid tissues World Health Organization classification of tumors. Lyon: IARC Press, pp 181\u2013184"},{"issue":"26","key":"1454_CR5","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1182\/blood-2014-03-563627","volume":"124","author":"D Hoelzer","year":"2014","unstructured":"Hoelzer D, Walewski J, Dohner H, et al. (2014) Improved outcome of adult Burkitt lymphoma\/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood 124(26):3870\u20133879. \n                    https:\/\/doi.org\/10.1182\/blood-2014-03-563627","journal-title":"Blood"},{"issue":"11","key":"1454_CR6","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3324\/haematol.2013.086827","volume":"98","author":"T Intermesoli","year":"2013","unstructured":"Intermesoli T, Rambaldi A, Rossi G, et al. (2013) High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica 98(11):1718\u20131725. \n                    https:\/\/doi.org\/10.3324\/haematol.2013.086827","journal-title":"Haematologica"},{"issue":"6","key":"1454_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/RLU.0b013e3181a34552","volume":"34","author":"W Zeng","year":"2009","unstructured":"Zeng W, Lechowicz MJ, Winton E, et al. (2009) Spectrum of FDG PET\/CT findings in Burkitt lymphoma. Clin Nucl Med 34(6):355\u2013358. \n                    https:\/\/doi.org\/10.1097\/RLU.0b013e3181a34552","journal-title":"Clin Nucl Med"},{"issue":"2","key":"1454_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1182\/blood-2007-07-101899","volume":"111","author":"TC Kwee","year":"2008","unstructured":"Kwee TC, Kwee RM, Nievelstein RA (2008) Imaging in staging of malignant lymphoma: a systematic review. Blood 111(2):504\u2013516. \n                    https:\/\/doi.org\/10.1182\/blood-2007-07-101899","journal-title":"Blood"},{"issue":"6","key":"1454_CR9","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1148\/rg.276065170","volume":"27","author":"NP Leite","year":"2007","unstructured":"Leite NP, Kased N, Hanna RF, et al. (2007) Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies. Radiographics 27(6):1613\u20131634. \n                    https:\/\/doi.org\/10.1148\/rg.276065170","journal-title":"Radiographics"},{"issue":"2","key":"1454_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1148\/radiology.206.2.9457202","volume":"206","author":"F Moog","year":"1998","unstructured":"Moog F, Bangerter M, Diederichs CG, et al. (1998) Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology 206(2):475\u2013481. \n                    https:\/\/doi.org\/10.1148\/radiology.206.2.9457202","journal-title":"Radiology"},{"issue":"3","key":"1454_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2214\/AJR.08.1160","volume":"192","author":"PA Jong de","year":"2009","unstructured":"de Jong PA, van Ufford HM, Baarslag HJ, et al. (2009) CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. AJR Am J Roentgenol 192(3):745\u2013753. \n                    https:\/\/doi.org\/10.2214\/AJR.08.1160","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"1454_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1148\/radiol.2323030985","volume":"232","author":"NG Schaefer","year":"2004","unstructured":"Schaefer NG, Hany TF, Taverna C, et al. (2004) Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging\u2013do we need contrast-enhanced CT? Radiology 232(3):823\u2013829. \n                    https:\/\/doi.org\/10.1148\/radiol.2323030985","journal-title":"Radiology"},{"issue":"10","key":"1454_CR13","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/annonc\/mdn282","volume":"19","author":"RL Elstrom","year":"2008","unstructured":"Elstrom RL, Leonard JP, Coleman M, Brown RK (2008) Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol 19(10):1770\u20131773. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdn282","journal-title":"Ann Oncol"},{"issue":"27","key":"1454_CR14","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, et al. (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068. \n                    https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"issue":"4","key":"1454_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/hon.2181","volume":"33","author":"E Carrillo-Cruz","year":"2015","unstructured":"Carrillo-Cruz E, Marin-Oyaga VA, de la Cruz Vicente F, et al. (2015) Role of 18F-FDG-PET\/CT in the management of marginal zone B cell lymphoma. Hematol Oncol 33(4):151\u2013158. \n                    https:\/\/doi.org\/10.1002\/hon.2181","journal-title":"Hematol Oncol"},{"issue":"6","key":"1454_CR16","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2214\/ajr.182.6.1821579","volume":"182","author":"U Metser","year":"2004","unstructured":"Metser U, Goor O, Lerman H, Naparstek E, Even-Sapir E (2004) PET-CT of extranodal lymphoma. AJR Am J Roentgenol 182(6):1579\u20131586. \n                    https:\/\/doi.org\/10.2214\/ajr.182.6.1821579","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"1454_CR17","first-page":"1072","volume":"44","author":"JN Rini","year":"2003","unstructured":"Rini JN, Leonidas JC, Tomas MB, Palestro CJ (2003) 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med 44(7):1072\u20131074","journal-title":"J Nucl Med"},{"issue":"1","key":"1454_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2214\/AJR.07.3146","volume":"191","author":"WK Lee","year":"2008","unstructured":"Lee WK, Lau EW, Duddalwar VA, Stanley AJ, Ho YY (2008) Abdominal manifestations of extranodal lymphoma: spectrum of imaging findings. AJR Am J Roentgenol 191(1):198\u2013206. \n                    https:\/\/doi.org\/10.2214\/AJR.07.3146","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"1454_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.5581\/1516-8484.20110035","volume":"33","author":"CA Buchpiguel","year":"2011","unstructured":"Buchpiguel CA (2011) Current status of PET\/CT in the diagnosis and follow up of lymphomas. Rev Bras Hematol Hemoter 33(2):140\u2013147. \n                    https:\/\/doi.org\/10.5581\/1516-8484.20110035","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"21","key":"1454_CR20","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","volume":"23","author":"H Schoder","year":"2005","unstructured":"Schoder H, Noy A, Gonen M, et al. (2005) Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol 23(21):4643\u20134651. \n                    https:\/\/doi.org\/10.1200\/JCO.2005.12.072","journal-title":"J Clin Oncol"},{"issue":"4","key":"1454_CR21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4103\/0971-3026.125626","volume":"23","author":"MM D\u2019Souza","year":"2013","unstructured":"D\u2019Souza MM, Jaimini A, Bansal A, et al. (2013) FDG-PET\/CT in lymphoma. Indian J Radiol Imaging 23(4):354\u2013365. \n                    https:\/\/doi.org\/10.4103\/0971-3026.125626","journal-title":"Indian J Radiol Imaging"},{"issue":"1","key":"1454_CR22","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1016\/j.ejrad.2009.07.035","volume":"75","author":"D Karantanis","year":"2010","unstructured":"Karantanis D, Durski JM, Lowe VJ, et al. (2010) 18F-FDG PET and PET\/CT in Burkitt\u2019s lymphoma. Eur J Radiol 75(1):e68\u201373. \n                    https:\/\/doi.org\/10.1016\/j.ejrad.2009.07.035","journal-title":"Eur J Radiol"},{"issue":"3","key":"1454_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1148\/radiology.154.3.3969481","volume":"154","author":"SP Strijk","year":"1985","unstructured":"Strijk SP, Wagener DJ, Bogman MJ, de Pauw BE, Wobbes T (1985) The spleen in Hodgkin disease: diagnostic value of CT. Radiology 154(3):753\u2013757. \n                    https:\/\/doi.org\/10.1148\/radiology.154.3.3969481","journal-title":"Radiology"},{"issue":"8","key":"1454_CR24","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/1097-0142(19951015)76:8<1460::AID-CNCR2820760825>3.0.CO;2-Y","volume":"76","author":"R Munker","year":"1995","unstructured":"Munker R, Stengel A, Stabler A, Hiller E, Brehm G (1995) Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin\u2019s disease. Verification by laparotomy in 100 cases. Cancer 76(8):1460\u20131466","journal-title":"Cancer"},{"issue":"4","key":"1454_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.rcl.2007.05.009","volume":"45","author":"E Even-Sapir","year":"2007","unstructured":"Even-Sapir E, Lievshitz G, Perry C, et al. (2007) Fluorine-18 fluorodeoxyglucose PET\/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin\u2019s disease. Radiol Clin North Am 45(4):697\u2013709. \n                    https:\/\/doi.org\/10.1016\/j.rcl.2007.05.009","journal-title":"Radiol Clin North Am"},{"issue":"7","key":"1454_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s00277-003-0631-3","volume":"82","author":"U Rueffer","year":"2003","unstructured":"Rueffer U, Sieber M, Stemberg M, et al. (2003) Spleen involvement in Hodgkin\u2019s lymphoma: assessment and risk profile. Ann Hematol 82(7):390\u2013396. \n                    https:\/\/doi.org\/10.1007\/s00277-003-0631-3","journal-title":"Ann Hematol"},{"issue":"1","key":"1454_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1148\/radiographics.21.1.g01ja02161","volume":"21","author":"A Guermazi","year":"2001","unstructured":"Guermazi A, Brice P, de Kerviler EE, et al. (2001) Extranodal Hodgkin disease: spectrum of disease. Radiographics 21(1):161\u2013179. \n                    https:\/\/doi.org\/10.1148\/radiographics.21.1.g01ja02161","journal-title":"Radiographics"},{"issue":"6","key":"1454_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3322\/canjclin.55.6.368","volume":"55","author":"JO Armitage","year":"2005","unstructured":"Armitage JO (2005) Staging non-Hodgkin lymphoma. CA Cancer J Clin 55(6):368\u2013376","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1454_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/028418518702800202","volume":"28","author":"SP Strijk","year":"1987","unstructured":"Strijk SP, Boetes C, Bogman MJ, de Pauw BE, Wobbes T (1987) The spleen in non-Hodgkin lymphoma. Diagnostic value of computed tomography. Acta Radiol 28(2):139\u2013144","journal-title":"Acta Radiol"},{"issue":"8","key":"1454_CR30","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.4065\/80.8.1087","volume":"80","author":"SM Ansell","year":"2005","unstructured":"Ansell SM, Armitage J (2005) Non-Hodgkin lymphoma: diagnosis and treatment. Mayo Clin Proc 80(8):1087\u20131097. \n                    https:\/\/doi.org\/10.4065\/80.8.1087","journal-title":"Mayo Clin Proc"},{"key":"1454_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/bjs.1800510404","volume":"51","author":"DH Wright","year":"1964","unstructured":"Wright DH (1964) Burkitt\u2019s tumour. A post-mortem study of 50 cases. Br J Surg 51:245\u2013251","journal-title":"Br J Surg"},{"issue":"13","key":"1454_CR32","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1056\/NEJM197609232951301","volume":"295","author":"RB Mann","year":"1976","unstructured":"Mann RB, Jaffe ES, Braylan RC, et al. (1976) Non-endemic Burkitt\u2019s lymphoma. A B-cell tumor related to germinal centers. N Engl J Med 295(13):685\u2013691","journal-title":"N Engl J Med"},{"issue":"1","key":"1454_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3324\/haematol.13574","volume":"94","author":"D Jong de","year":"2009","unstructured":"de Jong D, Koster A, Hagenbeek A, et al. (2009) Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. Haematologica 94(1):70\u201377","journal-title":"Haematologica"},{"issue":"10","key":"1454_CR34","doi-asserted-by":"publisher","first-page":"e1005158","DOI":"10.1371\/journal.ppat.1005158","volume":"11","author":"F Abate","year":"2015","unstructured":"Abate F, Ambrosio MR, Mundo L, et al. (2015) Distinct viral and mutational spectrum of Endemic Burkitt lymphoma. PLoS Pathog 11(10):e1005158. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1005158","journal-title":"PLoS Pathog"},{"issue":"23","key":"1454_CR35","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H, et al. (2006) A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med 354(23):2419\u20132430. \n                    https:\/\/doi.org\/10.1056\/NEJMoa055351","journal-title":"N Engl J Med"},{"issue":"1","key":"1454_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/PAS.0b013e3180959e09","volume":"32","author":"SJ Rodig","year":"2008","unstructured":"Rodig SJ, Vergilio JA, Shahsafaei A, Dorfman DM (2008) Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation. Am J Surg Pathol 32(1):113\u2013122. \n                    https:\/\/doi.org\/10.1097\/PAS.0b013e3180959e09","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1454_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1634\/theoncologist.11-4-375","volume":"11","author":"JA Ferry","year":"2006","unstructured":"Ferry JA (2006) Burkitt\u2019s lymphoma: clinicopathologic features and differential diagnosis. Oncologist 11(4):375\u2013383. \n                    https:\/\/doi.org\/10.1634\/theoncologist.11-4-375","journal-title":"Oncologist"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-017-1454-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-017-1454-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-017-1454-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:51:07Z","timestamp":1550537467000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-017-1454-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["1454"],"URL":"https:\/\/doi.org\/10.1007\/s00261-017-1454-3","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]},"assertion":[{"value":"19 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of Sheba Medical Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}